Gender-Specific Determinants of Tuberculosis Treatment Interruption in an Urban High- Burden African Setting: A Retrospective Cohort Study of Males in Nairobi, Kenya (2019– 2023)
This retrospective cohort study of 24,794 men in Nairobi (2019–2023) identifies malnutrition, adverse drug reactions, and alcohol use as key risk factors for tuberculosis treatment interruption, while highlighting that consistent clinic attendance serves as a strong protective factor, suggesting that targeted nutritional support and improved health system engagement are critical for improving treatment continuity in urban high-burden settings.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Tuberculosis is an ancient enemy that still claims more lives today than any other single infectious disease. While modern medicine offers a cure, the path to recovery is long and difficult, often requiring patients to take a strict regimen of pills for many months. The success of this treatment depends entirely on consistency; if a person stops taking their medicine before the infection is fully cleared, the bacteria can return stronger, harder to treat, and capable of spreading to others. This break in treatment, known as interruption, is a major obstacle to controlling the disease globally. In many places, men are disproportionately affected by tuberculosis and are also more likely to stop their treatment early, yet the specific reasons why they drop out have remained somewhat unclear, especially in crowded cities where daily life is fast-paced and resources are stretched thin.
Researchers in Nairobi, Kenya, set out to understand exactly what drives men to abandon their tuberculosis treatment. They looked back at the medical records of nearly 25,000 men who were diagnosed with the disease between 2019 and 2023. By examining the data of these patients, the team sought to identify the specific factors that made a man more likely to stop his care. They focused on three main areas: the patient's own health conditions, the side effects caused by the medication, and how often the patient visited the clinic to get his medicine and check-ups.
The study revealed that the decision to stop treatment is rarely about a single cause but rather a combination of physical vulnerability and how well the health system supports the patient. One of the most significant findings was that men who were undernourished were more likely to interrupt their treatment. When a person is malnourished, their body is weaker, and they may struggle with the physical demands of the illness or the discomfort of the medication, making it harder to stick to the daily routine of taking pills. The researchers found that being underweight increased the likelihood of dropping out, suggesting that providing food support alongside medical treatment could help keep patients on track.
Another critical factor was the reaction to the medicine itself. Although very few men in the study officially reported severe side effects, those who did were far more likely to stop treatment. The data showed that men who experienced adverse reactions, such as nausea or other harmful effects from the drugs, were ten times more likely to interrupt their care compared to those who did not. This suggests that even when side effects are not common, they are a powerful force that can push a patient away from the clinic. The researchers noted that these reactions might be underreported in routine records, meaning the problem could be even larger than the numbers show.
Perhaps the most powerful finding was about the relationship between the patient and the clinic. The study found that the more often a man visited the clinic to get his medicine and provide samples for testing, the less likely he was to stop treatment. In fact, every additional visit acted as a strong shield against dropping out. Men who attended all their scheduled appointments had a near-zero chance of interrupting their care, while those who missed visits faced a much higher risk of giving up. This highlights that keeping a patient engaged with their healthcare provider is one of the most effective ways to ensure they finish their treatment.
The researchers also looked at other common factors, such as whether a man had diabetes, used alcohol, or had a family member helping him with his treatment. They found that while alcohol use was linked to a higher risk of stopping treatment, having a support person at home did not make a statistical difference in this group, likely because almost all the men in the study already had someone helping them. Interestingly, having diabetes did not appear to change the likelihood of stopping treatment in this specific group of men, which differs from findings in other parts of the world. The study also confirmed that men with the most common form of the disease, which affects the lungs, were more likely to interrupt care than those with the less common form that affects other parts of the body.
Ultimately, this research paints a clear picture of the challenges facing men with tuberculosis in a busy urban environment. It shows that treatment interruption is not just a matter of willpower but is deeply influenced by physical health, the management of medication side effects, and the frequency of contact with healthcare workers. The findings suggest that to save more lives, health programs need to do more than just prescribe medicine. They must integrate nutritional support to strengthen vulnerable patients, improve the monitoring and management of drug side effects so they can be treated quickly, and design clinic schedules that make it easier for working men to stay engaged with their care. By addressing these specific barriers, health systems can help more men complete their treatment and move closer to the goal of eliminating tuberculosis as a public health threat.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.